NDC 73289-0060-3 - Formoterol Fumarate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 73289-0060
- Requested NDC
- 73289-0060-3
- Package NDCs from labels
- 73289-0060-3, 73289-0060-1, 73289-0060-2
- Manufacturer
- Aucta Pharmaceuticals, Inc
- Effective date
- 2024-12-05
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Formoterol Fumarate - Aucta Pharmaceuticals, Inc | Aucta Pharmaceuticals, Inc | 2024-12-05 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 73289-0060-1 | ML - Milliliter | 73289-0060 | 661e1990-3907-4a64-861a-5af1db750606 | 1 | 2023-02-06 |
| 73289-0060-2 | ML - Milliliter | 73289-0060 | f87378e0-da31-4329-abd5-26316ccef956 | 1 | 2023-02-06 |
| 73289-0060-3 | ML - Milliliter | 73289-0060 | 11fa1ca9-5e8e-4f98-a3ce-6156ba67d2a9 | 1 | 2023-02-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Formoterol fumarate | FORMOTEROL FUMARATE | Bryant Ranch Prepack | 9786f3e2-4265-4246-9999-f73cd6b33fc8 | 2024-01-11 | Warnings, Adverse reactions | W34SHF8J2K |
| BEVESPI AEROSPHERE | GLYCOPYRROLATE AND FORMOTEROL FUMARATE | AstraZeneca Pharmaceuticals LP | ae02436e-9528-490e-a844-0c0f6f2843f9 | 2023-03-24 | Warnings, Adverse reactions | W34SHF8J2K |
| Budesonide and Formoterol Fumarate Dihydrate | BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE | A-S Medication Solutions | 0ce4cd21-ac96-4b39-9e1c-49f86c87fa1a | 2023-02-06 | Warnings, Adverse reactions | W34SHF8J2K |
| Budesonide and formoterol fumarate dihydrate | BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE | Teva Pharmaceuticals, Inc. | dd352302-e2fe-4388-b4b0-00b34f6ebe48 | 2022-11-01 | Warnings, Adverse reactions | W34SHF8J2K |
| DUAKLIR PRESSAIR | ACLIDINIUM BROMIDE AND FORMOTEROL FUMARATE | Covis Pharma US, Inc | 2eba3089-28b4-4190-9fba-2511246cfd16 | 2022-08-01 | Warnings, Adverse reactions | W34SHF8J2K |
| FORMOTEROL FUMARATE | FORMOTEROL FUMARATE DIHYDRATE | Mylan Pharmaceuticals Inc. | 6c1a6c53-af85-4220-9ce3-2373e0928f7f | 2020-12-15 | Warnings, Adverse reactions | W34SHF8J2K |
| Formoterol fumarate | FORMOTEROL FUMARATE | Teva Pharmaceuticals USA, Inc. | 419bc85d-8e24-478b-921e-babfb73e79f3 | 2020-10-31 | Warnings, Adverse reactions | W34SHF8J2K |
| SYMBICORT | BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE | AstraZeneca Pharmaceuticals LP | fafa4cf1-99c2-43d5-73ad-51f256de3be0 | 2019-07-24 | Warnings, Adverse reactions | W34SHF8J2K |
| Budesonide and Formoterol Fumarate Dihydrate | BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE | AstraZeneca Pharmaceuticals LP | 1d266fe8-52e3-4f85-a037-c5c1afa15e60 | 2019-07-24 | Warnings, Adverse reactions | W34SHF8J2K |
| Perforomist | FORMOTEROL FUMARATE DIHYDRATE | Viatris Specialty LLC | fb2fe258-fe2e-47f6-8adf-ca75bf6f90af | 2019-05-31 | Warnings, Adverse reactions | W34SHF8J2K |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.